The department of Nuclear Medicine SKIMS conducted the first case of Sentinal Lymph node Scintigraphy in breast cancer patients on Saturday.
In a statement, a spokesperson said the sample will be taken for SLN biopsy by the department of surgical oncology, while this is another major milestone achieved by the department, benefitting cancer patients.
As per the statement, the Head of the Department Dr Tanvir Ahmad informed that patients of breast cancer, tongue cancer and melanoma are going to get benefitted from this procedure.
“The procedure is first of its kind available to the patients of J-K and will go a long way in improving the treatment of cancer patients.”
He, as per the statement, explained that the Lymphoscintigraphy is an imaging technique that is used to identify the lymph drainage basin, determine the number of sentinel nodes, differentiate sentinel nodes from subsequent nodes, locate the sentinel node in an unexpected location, and mark the sentinel node over the skin for biopsy.
Meanwhile, director SKIMS Prof. Parvaiz A Koul complimented the department for conducting the procedure. “The advanced procedure will help poor patients which will be conducted now routinely at SKIMS.”
He added the patients had to go outside for such procedures facing a lot of inconveniences and incurring a lot of expenditures, the procedure now available at SKIMS will facilitate such patients. (KNO)
